SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,123.83 -125.56
( -0.17%)

Global Indices

Nasdaq

52,891.50 14.41
(0.03%)

Dow Jones

7,684.38 -93.79
(-1.21%)

Hang Seng

62,584.98 -322.86
(-0.51%)

Nikkei 225

10,670.63 -54.40
(-0.51%)

Forex

USD-INR

94.51 -0.31
(-0.33%)

EUR-INR

106.10 -0.35
(-0.33%)

GBP-INR

126.51 -0.13
(-0.10%)

JPY-INR

0.60 0.00
(-0.28%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Hikal Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524735

INE475B01022

97.2386745

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

HIKAL

58.63

2501.16

EPS(TTM)

Face Value()

Div & Yield %

3.46

0.3

Back

orchid pharma ltd

ITC consolidated net profit declines 16.21% in the June 2026 quarter

Aug 01,2026

Net profit of ITC declined 16.21% to Rs 4394.13 crore in the quarter ended June 2026 as against Rs 5244.20 crore during the previous quarter ended June 2025. Sales declined 11.10% to Rs 19000.89 crore in the quarter ended June 2026 as against Rs 21372.93 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	19000.89	21372.93	-11
OPM %	27.27	31.89	-
PBDT	5882.70	7550.97	-22
PBT	5454.97	7128.01	-23
NP	4394.13	5244.20	-16

73,123.83 -125.56 ( -0.17%)

52,891.50 14.41 (0.03%)

7,684.38 -93.79 (-1.21%)

62,584.98 -322.86 (-0.51%)

10,670.63 -54.40 (-0.51%)

94.51 -0.31 (-0.33%)

106.10 -0.35 (-0.33%)

126.51 -0.13 (-0.10%)

0.60 0.00 (-0.28%)